nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Tamoxifen—pancreatic cancer	0.109	0.182	CbGbCtD
Metronidazole—CYP2C8—Erlotinib—pancreatic cancer	0.0927	0.155	CbGbCtD
Metronidazole—CYP2C8—Fluorouracil—pancreatic cancer	0.0804	0.134	CbGbCtD
Metronidazole—CYP2C9—Tamoxifen—pancreatic cancer	0.0761	0.127	CbGbCtD
Metronidazole—CYP2C9—Fluorouracil—pancreatic cancer	0.0561	0.0937	CbGbCtD
Metronidazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0442	0.0739	CbGbCtD
Metronidazole—CYP3A4—Erlotinib—pancreatic cancer	0.0376	0.0629	CbGbCtD
Metronidazole—CYP3A4—Irinotecan—pancreatic cancer	0.034	0.0568	CbGbCtD
Metronidazole—CYP3A4—Docetaxel—pancreatic cancer	0.0249	0.0416	CbGbCtD
Metronidazole—CYP3A4—Sunitinib—pancreatic cancer	0.0248	0.0414	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—pancreatic cancer	0.0186	0.031	CbGbCtD
Metronidazole—Abdominal distension—Doxorubicin—pancreatic cancer	0.000222	0.000553	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000222	0.000552	CcSEcCtD
Metronidazole—Urticaria—Fluorouracil—pancreatic cancer	0.000221	0.000551	CcSEcCtD
Metronidazole—Headache—Sunitinib—pancreatic cancer	0.000221	0.000551	CcSEcCtD
Metronidazole—Syncope—Docetaxel—pancreatic cancer	0.000221	0.00055	CcSEcCtD
Metronidazole—Asthma—Doxorubicin—pancreatic cancer	0.000221	0.00055	CcSEcCtD
Metronidazole—Influenza—Doxorubicin—pancreatic cancer	0.000221	0.00055	CcSEcCtD
Metronidazole—Leukopenia—Docetaxel—pancreatic cancer	0.000221	0.000549	CcSEcCtD
Metronidazole—Pollakiuria—Epirubicin—pancreatic cancer	0.00022	0.000549	CcSEcCtD
Metronidazole—Body temperature increased—Fluorouracil—pancreatic cancer	0.00022	0.000549	CcSEcCtD
Metronidazole—Eosinophilia—Doxorubicin—pancreatic cancer	0.000219	0.000544	CcSEcCtD
Metronidazole—Palpitations—Docetaxel—pancreatic cancer	0.000218	0.000542	CcSEcCtD
Metronidazole—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000218	0.000542	CcSEcCtD
Metronidazole—Loss of consciousness—Docetaxel—pancreatic cancer	0.000217	0.00054	CcSEcCtD
Metronidazole—Pancreatitis—Doxorubicin—pancreatic cancer	0.000216	0.000539	CcSEcCtD
Metronidazole—Hypersensitivity—Irinotecan—pancreatic cancer	0.000214	0.000534	CcSEcCtD
Metronidazole—Convulsion—Docetaxel—pancreatic cancer	0.000214	0.000532	CcSEcCtD
Metronidazole—Hypertension—Docetaxel—pancreatic cancer	0.000213	0.00053	CcSEcCtD
Metronidazole—Infestation—Epirubicin—pancreatic cancer	0.000213	0.00053	CcSEcCtD
Metronidazole—Drowsiness—Epirubicin—pancreatic cancer	0.000213	0.00053	CcSEcCtD
Metronidazole—Infestation NOS—Epirubicin—pancreatic cancer	0.000213	0.00053	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—pancreatic cancer	0.000212	0.000529	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000211	0.000525	CcSEcCtD
Metronidazole—Arthralgia—Docetaxel—pancreatic cancer	0.00021	0.000523	CcSEcCtD
Metronidazole—Chest pain—Docetaxel—pancreatic cancer	0.00021	0.000523	CcSEcCtD
Metronidazole—Nausea—Sunitinib—pancreatic cancer	0.00021	0.000523	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—pancreatic cancer	0.00021	0.000522	CcSEcCtD
Metronidazole—Asthenia—Irinotecan—pancreatic cancer	0.000209	0.00052	CcSEcCtD
Metronidazole—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000209	0.000519	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000208	0.000519	CcSEcCtD
Metronidazole—Jaundice—Epirubicin—pancreatic cancer	0.000207	0.000516	CcSEcCtD
Metronidazole—Stomatitis—Epirubicin—pancreatic cancer	0.000207	0.000516	CcSEcCtD
Metronidazole—Urinary tract infection—Epirubicin—pancreatic cancer	0.000207	0.000515	CcSEcCtD
Metronidazole—Conjunctivitis—Epirubicin—pancreatic cancer	0.000207	0.000515	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—pancreatic cancer	0.000206	0.000514	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—pancreatic cancer	0.000206	0.000514	CcSEcCtD
Metronidazole—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000205	0.000511	CcSEcCtD
Metronidazole—Dry mouth—Docetaxel—pancreatic cancer	0.000205	0.000511	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000205	0.000511	CcSEcCtD
Metronidazole—Sweating—Epirubicin—pancreatic cancer	0.000204	0.000508	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—pancreatic cancer	0.000204	0.000508	CcSEcCtD
Metronidazole—Asthenia—Gemcitabine—pancreatic cancer	0.000203	0.000506	CcSEcCtD
Metronidazole—Confusional state—Docetaxel—pancreatic cancer	0.000203	0.000505	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000202	0.000502	CcSEcCtD
Metronidazole—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000201	0.000501	CcSEcCtD
Metronidazole—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000201	0.000501	CcSEcCtD
Metronidazole—Oedema—Docetaxel—pancreatic cancer	0.000201	0.000501	CcSEcCtD
Metronidazole—Pruritus—Gemcitabine—pancreatic cancer	0.000201	0.000499	CcSEcCtD
Metronidazole—Infection—Docetaxel—pancreatic cancer	0.0002	0.000498	CcSEcCtD
Metronidazole—Sinusitis—Epirubicin—pancreatic cancer	0.0002	0.000497	CcSEcCtD
Metronidazole—Diarrhoea—Irinotecan—pancreatic cancer	0.000199	0.000496	CcSEcCtD
Metronidazole—Agranulocytosis—Epirubicin—pancreatic cancer	0.000199	0.000494	CcSEcCtD
Metronidazole—Shock—Docetaxel—pancreatic cancer	0.000198	0.000493	CcSEcCtD
Metronidazole—Nervous system disorder—Docetaxel—pancreatic cancer	0.000197	0.000491	CcSEcCtD
Metronidazole—Pruritus—Fluorouracil—pancreatic cancer	0.000197	0.000491	CcSEcCtD
Metronidazole—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000197	0.00049	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—pancreatic cancer	0.000197	0.00049	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—pancreatic cancer	0.000197	0.00049	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—pancreatic cancer	0.000197	0.00049	CcSEcCtD
Metronidazole—Skin disorder—Docetaxel—pancreatic cancer	0.000195	0.000487	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000195	0.000486	CcSEcCtD
Metronidazole—Diarrhoea—Gemcitabine—pancreatic cancer	0.000194	0.000483	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000193	0.000481	CcSEcCtD
Metronidazole—Dizziness—Irinotecan—pancreatic cancer	0.000192	0.000479	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—pancreatic cancer	0.000192	0.000478	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—pancreatic cancer	0.000192	0.000478	CcSEcCtD
Metronidazole—Anorexia—Docetaxel—pancreatic cancer	0.000192	0.000478	CcSEcCtD
Metronidazole—Rhinitis—Epirubicin—pancreatic cancer	0.000191	0.000477	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000191	0.000476	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000191	0.000476	CcSEcCtD
Metronidazole—Hepatitis—Epirubicin—pancreatic cancer	0.000191	0.000476	CcSEcCtD
Metronidazole—Diarrhoea—Fluorouracil—pancreatic cancer	0.000191	0.000475	CcSEcCtD
Metronidazole—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00019	0.000473	CcSEcCtD
Metronidazole—Pharyngitis—Epirubicin—pancreatic cancer	0.00019	0.000472	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—pancreatic cancer	0.000189	0.00047	CcSEcCtD
Metronidazole—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000188	0.000467	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000186	0.000464	CcSEcCtD
Metronidazole—Vomiting—Irinotecan—pancreatic cancer	0.000185	0.000461	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—pancreatic cancer	0.000185	0.00046	CcSEcCtD
Metronidazole—Dizziness—Fluorouracil—pancreatic cancer	0.000184	0.000459	CcSEcCtD
Metronidazole—Visual impairment—Epirubicin—pancreatic cancer	0.000184	0.000458	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000184	0.000457	CcSEcCtD
Metronidazole—Rash—Irinotecan—pancreatic cancer	0.000183	0.000457	CcSEcCtD
Metronidazole—Dermatitis—Irinotecan—pancreatic cancer	0.000183	0.000457	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000183	0.000456	CcSEcCtD
Metronidazole—Headache—Irinotecan—pancreatic cancer	0.000182	0.000454	CcSEcCtD
Metronidazole—Insomnia—Docetaxel—pancreatic cancer	0.000182	0.000453	CcSEcCtD
Metronidazole—Paraesthesia—Docetaxel—pancreatic cancer	0.000181	0.00045	CcSEcCtD
Metronidazole—Erythema multiforme—Epirubicin—pancreatic cancer	0.000181	0.00045	CcSEcCtD
Metronidazole—Vomiting—Gemcitabine—pancreatic cancer	0.00018	0.000449	CcSEcCtD
Metronidazole—Somnolence—Docetaxel—pancreatic cancer	0.000179	0.000445	CcSEcCtD
Metronidazole—Rash—Gemcitabine—pancreatic cancer	0.000179	0.000445	CcSEcCtD
Metronidazole—Dermatitis—Gemcitabine—pancreatic cancer	0.000179	0.000445	CcSEcCtD
Metronidazole—Eye disorder—Epirubicin—pancreatic cancer	0.000178	0.000444	CcSEcCtD
Metronidazole—Tinnitus—Epirubicin—pancreatic cancer	0.000178	0.000443	CcSEcCtD
Metronidazole—Headache—Gemcitabine—pancreatic cancer	0.000178	0.000442	CcSEcCtD
Metronidazole—Flushing—Epirubicin—pancreatic cancer	0.000177	0.000441	CcSEcCtD
Metronidazole—Cardiac disorder—Epirubicin—pancreatic cancer	0.000177	0.000441	CcSEcCtD
Metronidazole—Vomiting—Fluorouracil—pancreatic cancer	0.000177	0.000441	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—pancreatic cancer	0.000177	0.000441	CcSEcCtD
Metronidazole—Dyspepsia—Docetaxel—pancreatic cancer	0.000177	0.000441	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—pancreatic cancer	0.000177	0.00044	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000176	0.000438	CcSEcCtD
Metronidazole—Rash—Fluorouracil—pancreatic cancer	0.000176	0.000438	CcSEcCtD
Metronidazole—Dermatitis—Fluorouracil—pancreatic cancer	0.000176	0.000437	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—pancreatic cancer	0.000175	0.000437	CcSEcCtD
Metronidazole—Decreased appetite—Docetaxel—pancreatic cancer	0.000175	0.000435	CcSEcCtD
Metronidazole—Headache—Fluorouracil—pancreatic cancer	0.000175	0.000435	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000174	0.000433	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000174	0.000432	CcSEcCtD
Metronidazole—Fatigue—Docetaxel—pancreatic cancer	0.000173	0.000432	CcSEcCtD
Metronidazole—Angiopathy—Epirubicin—pancreatic cancer	0.000173	0.000432	CcSEcCtD
Metronidazole—Nausea—Irinotecan—pancreatic cancer	0.000173	0.00043	CcSEcCtD
Metronidazole—Immune system disorder—Epirubicin—pancreatic cancer	0.000173	0.00043	CcSEcCtD
Metronidazole—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000172	0.000429	CcSEcCtD
Metronidazole—Constipation—Docetaxel—pancreatic cancer	0.000172	0.000428	CcSEcCtD
Metronidazole—Pain—Docetaxel—pancreatic cancer	0.000172	0.000428	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—pancreatic cancer	0.00017	0.000424	CcSEcCtD
Metronidazole—Nausea—Gemcitabine—pancreatic cancer	0.000168	0.000419	CcSEcCtD
Metronidazole—Mental disorder—Epirubicin—pancreatic cancer	0.000167	0.000417	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000167	0.000416	CcSEcCtD
Metronidazole—Erythema—Epirubicin—pancreatic cancer	0.000166	0.000414	CcSEcCtD
Metronidazole—Feeling abnormal—Docetaxel—pancreatic cancer	0.000166	0.000413	CcSEcCtD
Metronidazole—Nausea—Fluorouracil—pancreatic cancer	0.000166	0.000412	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—pancreatic cancer	0.000165	0.000411	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—pancreatic cancer	0.000165	0.00041	CcSEcCtD
Metronidazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000165	0.00041	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—pancreatic cancer	0.000164	0.000408	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000164	0.000408	CcSEcCtD
Metronidazole—Flatulence—Epirubicin—pancreatic cancer	0.000164	0.000408	CcSEcCtD
Metronidazole—Dysgeusia—Epirubicin—pancreatic cancer	0.000163	0.000405	CcSEcCtD
Metronidazole—Back pain—Epirubicin—pancreatic cancer	0.000161	0.0004	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—pancreatic cancer	0.00016	0.000399	CcSEcCtD
Metronidazole—Muscle spasms—Epirubicin—pancreatic cancer	0.00016	0.000398	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—pancreatic cancer	0.00016	0.000397	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000159	0.000397	CcSEcCtD
Metronidazole—Body temperature increased—Docetaxel—pancreatic cancer	0.000159	0.000396	CcSEcCtD
Metronidazole—Abdominal pain—Docetaxel—pancreatic cancer	0.000159	0.000396	CcSEcCtD
Metronidazole—Vision blurred—Epirubicin—pancreatic cancer	0.000157	0.00039	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—pancreatic cancer	0.000155	0.000386	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—pancreatic cancer	0.000154	0.000383	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—pancreatic cancer	0.000152	0.000377	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—pancreatic cancer	0.000151	0.000375	CcSEcCtD
Metronidazole—Malaise—Epirubicin—pancreatic cancer	0.00015	0.000373	CcSEcCtD
Metronidazole—Vertigo—Epirubicin—pancreatic cancer	0.000149	0.000372	CcSEcCtD
Metronidazole—Syncope—Epirubicin—pancreatic cancer	0.000149	0.000371	CcSEcCtD
Metronidazole—Leukopenia—Epirubicin—pancreatic cancer	0.000149	0.000371	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—pancreatic cancer	0.000149	0.000371	CcSEcCtD
Metronidazole—Hypersensitivity—Docetaxel—pancreatic cancer	0.000148	0.000369	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—pancreatic cancer	0.000148	0.000368	CcSEcCtD
Metronidazole—Palpitations—Epirubicin—pancreatic cancer	0.000147	0.000366	CcSEcCtD
Metronidazole—Loss of consciousness—Epirubicin—pancreatic cancer	0.000146	0.000364	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—pancreatic cancer	0.000145	0.000361	CcSEcCtD
Metronidazole—Asthenia—Docetaxel—pancreatic cancer	0.000144	0.000359	CcSEcCtD
Metronidazole—Convulsion—Epirubicin—pancreatic cancer	0.000144	0.000359	CcSEcCtD
Metronidazole—Hypertension—Epirubicin—pancreatic cancer	0.000144	0.000357	CcSEcCtD
Metronidazole—Pruritus—Docetaxel—pancreatic cancer	0.000142	0.000354	CcSEcCtD
Metronidazole—Arthralgia—Epirubicin—pancreatic cancer	0.000142	0.000352	CcSEcCtD
Metronidazole—Chest pain—Epirubicin—pancreatic cancer	0.000142	0.000352	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000141	0.00035	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—pancreatic cancer	0.000139	0.000345	CcSEcCtD
Metronidazole—Dry mouth—Epirubicin—pancreatic cancer	0.000138	0.000345	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—pancreatic cancer	0.000138	0.000344	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—pancreatic cancer	0.000138	0.000344	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—pancreatic cancer	0.000138	0.000343	CcSEcCtD
Metronidazole—Diarrhoea—Docetaxel—pancreatic cancer	0.000138	0.000343	CcSEcCtD
Metronidazole—Confusional state—Epirubicin—pancreatic cancer	0.000137	0.000341	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—pancreatic cancer	0.000136	0.000339	CcSEcCtD
Metronidazole—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000136	0.000338	CcSEcCtD
Metronidazole—Oedema—Epirubicin—pancreatic cancer	0.000136	0.000338	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000135	0.000337	CcSEcCtD
Metronidazole—Infection—Epirubicin—pancreatic cancer	0.000135	0.000336	CcSEcCtD
Metronidazole—Shock—Epirubicin—pancreatic cancer	0.000134	0.000332	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—pancreatic cancer	0.000133	0.000332	CcSEcCtD
Metronidazole—Nervous system disorder—Epirubicin—pancreatic cancer	0.000133	0.000331	CcSEcCtD
Metronidazole—Dizziness—Docetaxel—pancreatic cancer	0.000133	0.000331	CcSEcCtD
Metronidazole—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000133	0.000331	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—pancreatic cancer	0.000133	0.000331	CcSEcCtD
Metronidazole—Skin disorder—Epirubicin—pancreatic cancer	0.000132	0.000328	CcSEcCtD
Metronidazole—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000131	0.000327	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—pancreatic cancer	0.000131	0.000326	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—pancreatic cancer	0.000131	0.000326	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00013	0.000324	CcSEcCtD
Metronidazole—Anorexia—Epirubicin—pancreatic cancer	0.000129	0.000322	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—pancreatic cancer	0.000128	0.000319	CcSEcCtD
Metronidazole—Vomiting—Docetaxel—pancreatic cancer	0.000128	0.000319	CcSEcCtD
Metronidazole—Rash—Docetaxel—pancreatic cancer	0.000127	0.000316	CcSEcCtD
Metronidazole—Dermatitis—Docetaxel—pancreatic cancer	0.000127	0.000316	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—pancreatic cancer	0.000127	0.000315	CcSEcCtD
Metronidazole—Headache—Docetaxel—pancreatic cancer	0.000126	0.000314	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000126	0.000313	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—pancreatic cancer	0.000126	0.000313	CcSEcCtD
Metronidazole—Infection—Doxorubicin—pancreatic cancer	0.000125	0.000311	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000124	0.000308	CcSEcCtD
Metronidazole—Shock—Doxorubicin—pancreatic cancer	0.000124	0.000308	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000123	0.000307	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000123	0.000306	CcSEcCtD
Metronidazole—Insomnia—Epirubicin—pancreatic cancer	0.000123	0.000306	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—pancreatic cancer	0.000122	0.000304	CcSEcCtD
Metronidazole—Paraesthesia—Epirubicin—pancreatic cancer	0.000122	0.000303	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000121	0.000302	CcSEcCtD
Metronidazole—Somnolence—Epirubicin—pancreatic cancer	0.000121	0.0003	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—pancreatic cancer	0.00012	0.000298	CcSEcCtD
Metronidazole—Nausea—Docetaxel—pancreatic cancer	0.000119	0.000298	CcSEcCtD
Metronidazole—Dyspepsia—Epirubicin—pancreatic cancer	0.000119	0.000297	CcSEcCtD
Metronidazole—Decreased appetite—Epirubicin—pancreatic cancer	0.000118	0.000294	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000117	0.000292	CcSEcCtD
Metronidazole—Fatigue—Epirubicin—pancreatic cancer	0.000117	0.000291	CcSEcCtD
Metronidazole—Pain—Epirubicin—pancreatic cancer	0.000116	0.000289	CcSEcCtD
Metronidazole—Constipation—Epirubicin—pancreatic cancer	0.000116	0.000289	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000114	0.000285	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—pancreatic cancer	0.000114	0.000283	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—pancreatic cancer	0.000113	0.000281	CcSEcCtD
Metronidazole—Feeling abnormal—Epirubicin—pancreatic cancer	0.000112	0.000278	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—pancreatic cancer	0.000112	0.000278	CcSEcCtD
Metronidazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000111	0.000276	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—pancreatic cancer	0.000111	0.000275	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—pancreatic cancer	0.000109	0.000272	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000108	0.00027	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—pancreatic cancer	0.000108	0.00027	CcSEcCtD
Metronidazole—Urticaria—Epirubicin—pancreatic cancer	0.000108	0.000268	CcSEcCtD
Metronidazole—Pain—Doxorubicin—pancreatic cancer	0.000107	0.000267	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—pancreatic cancer	0.000107	0.000267	CcSEcCtD
Metronidazole—Body temperature increased—Epirubicin—pancreatic cancer	0.000107	0.000267	CcSEcCtD
Metronidazole—Abdominal pain—Epirubicin—pancreatic cancer	0.000107	0.000267	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000103	0.000258	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000103	0.000256	CcSEcCtD
Metronidazole—Hypersensitivity—Epirubicin—pancreatic cancer	0.0001	0.000249	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—pancreatic cancer	9.97e-05	0.000248	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—pancreatic cancer	9.93e-05	0.000247	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—pancreatic cancer	9.93e-05	0.000247	CcSEcCtD
Metronidazole—Asthenia—Epirubicin—pancreatic cancer	9.74e-05	0.000242	CcSEcCtD
Metronidazole—Pruritus—Epirubicin—pancreatic cancer	9.6e-05	0.000239	CcSEcCtD
Metronidazole—Diarrhoea—Epirubicin—pancreatic cancer	9.28e-05	0.000231	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—pancreatic cancer	9.25e-05	0.00023	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—pancreatic cancer	9.01e-05	0.000224	CcSEcCtD
Metronidazole—Dizziness—Epirubicin—pancreatic cancer	8.97e-05	0.000223	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—pancreatic cancer	8.88e-05	0.000221	CcSEcCtD
Metronidazole—Vomiting—Epirubicin—pancreatic cancer	8.63e-05	0.000215	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—pancreatic cancer	8.59e-05	0.000214	CcSEcCtD
Metronidazole—Rash—Epirubicin—pancreatic cancer	8.56e-05	0.000213	CcSEcCtD
Metronidazole—Dermatitis—Epirubicin—pancreatic cancer	8.55e-05	0.000213	CcSEcCtD
Metronidazole—Headache—Epirubicin—pancreatic cancer	8.5e-05	0.000212	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—pancreatic cancer	8.3e-05	0.000207	CcSEcCtD
Metronidazole—Nausea—Epirubicin—pancreatic cancer	8.06e-05	0.000201	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—pancreatic cancer	7.98e-05	0.000199	CcSEcCtD
Metronidazole—Rash—Doxorubicin—pancreatic cancer	7.92e-05	0.000197	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—pancreatic cancer	7.91e-05	0.000197	CcSEcCtD
Metronidazole—Headache—Doxorubicin—pancreatic cancer	7.87e-05	0.000196	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—pancreatic cancer	7.46e-05	0.000186	CcSEcCtD
